Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2
Current Medical Science · 2024
DOI: 10.1007/s11596-024-2940-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Medical Science, 2024. Verfasst von Mei-Xia Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Wuhan Fourth Hospital, Wuhan, 430033, China. Hauptthemen laut MEDLINE: MicroRNAs, Pulmonary Fibrosis, Bleomycin, Respiratory Distress Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Acute respiratory distress syndrome (ARDS) patients currently have relatively high mortality, which is associated with early lung fibrosis. This study aimed to investigate whether miR-17 suppression could alleviate ARDS-associated lung fibrosis by regulating Mfn2. METHODS: A mouse model of ARDS-related lung fibrosis was constructed via intratracheal instillation of bleomycin. The expression level of miR-17 in lung tissues was detected via quantitative real time polymerase chain reaction (qRT-PCR). In the ARDS mouse model of lung fibrosis, the mitigating effects of miR-17 interference were evaluated via tail vein injection of the miR negative control or the miR-17 antagomir. The pathological changes in the lung tissue were examined via HE staining and Masson's trichrome staining, and the underlying molecular mechanism was investigated via ELISA, qRT-PCR and Western blotting. RESULTS: Bleomycin-induced pulmonary fibrosis significantly increased collagen deposition and the levels of hydroxyproline (HYP) and miR-17. Interfering with miR-17 significantly reduced the levels of HYP and miR-17 and upregulated the expression of Mfn2. The intravenous injection of the miR-17 antagomir alleviated lung inflammation and reduced collagen deposition. In addition, interference with miR-17 could upregulate LC3B expression, downregulate p62 expression, and improve mitochondrial structure. CONCLUSION: Interfering with miR-17 can improve pulmonary fibrosis in mice by promoting mitochondrial autophagy via Mfn2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Wuhan Fourth Hospital, Wuhan, 430033, China.
- Department of Critical Care Medicine, Wuhan Fourth Hospital, Wuhan, 430033, China. 5955098@qq.com.
- Institute of Anesthesiology and Critical Care, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. 2009xh0867@hust.edu.cn.
Zitieren
APA
Xu, M. X., Xu, T., & An, N. (2024). Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2. Current Medical Science. https://doi.org/10.1007/s11596-024-2940-9
Vancouver
Xu MX, Xu T, An N. Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2. Current Medical Science. 2024. doi:10.1007/s11596-024-2940-9
BibTeX
@article{Xu2024,
author = {Xu, Mei-Xia and Xu, Tao and An, Ning},
title = {Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2},
journal = {Current Medical Science},
year = {2024},
doi = {10.1007/s11596-024-2940-9}
}
EUVIMED